在COPD恶化期间,Baicalin可以恢复先天性淋巴细胞免疫失衡
Xuemei Liu1,2, Ai Luo1, Mei Yang1,3
1Department of Internal Medicine, Division of Pulmonary Medicine, Institute of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University, Chengdu, China.
Immunologic research
|April 15, 2025
概括
拜卡林可以通过恢复免疫平衡来治疗慢性阻塞性肺病 (COPD) 的恶化. 这项研究表明,百卡林恢复了先天性淋巴细胞2型 (ILC2) 免疫力,并降低了IL-22,这是COPD恶化的一个关键因素.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 恶化涉及免疫失调,特别是在先天性淋巴细胞 (ILC) 反应中.
- 在COPD恶化 (ECOPD) 期间观察到ILC免疫力失衡,包括降低ILC2和增加ILC1/ILC3.
- 在ECOPD期间IL-22在介导ILC免疫抑制中的作用尚未完全理解.
研究的目的:
- 研究COPD患者和ECOPD小鼠模型中的ILC免疫反应.
- 探索IL-22在ECOPD相关ILC失衡中的作用背后的分子机制.
- 评估贝卡林在恢复ECOPD期间ILC免疫恒温的治疗潜力.
主要方法:
- 在稳定的COPD患者和恶化期间对ILC的横截面分析.
- 在香烟烟雾和LPS诱导的ECOPD小鼠模型中验证临床发现.
- 在实验ECOPD模型中使用蛋白质组学和转录组学研究贝卡林对ILC和IL-22的影响.
主要成果:
- 慢性肺炎恶化显示ILC2免疫力下降和ILC1/ILC3反应增加,与IL-22.2升高相关.
- 在ECOPD小鼠中,复合IL-22的使用破坏了肺ILC的稳态,并抑制了ILC2的积累.
- 拜卡林治疗恢复了ILC2的免疫力,抑制了ILC1/ILC3,并减弱了ILC3.3产生的IL-22的产生.
结论:
- 通过促进1型和3型免疫力,IL-22在ECOPD中调解2型免疫抑制.
- 巴伊卡林通过恢复ILC2免疫力和抑制IL-22.2来显示ECOPD的治疗潜力.
- 贝卡林可以作为一种新的策略,用于管理COPD恶化的免疫失调.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
133
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
133
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
260
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
260
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20COPD: Pathogenesis and Clinical Features
185
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
185
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K